Registration - In-house Corporation

AstraZeneca Canada Inc. / Gaby Bourbara, President

Registration Information

In-house Corporation name: AstraZeneca Canada Inc.
Responsible Officer Name: Gaby Bourbara, President
Responsible Officer Change History
Initial registration start date: 2007-03-08
Registration status: Active
Registration Number: 957438-15042

Associated Communications

Total Number of Communication Reports: 159

Monthly communication reports in the last 6 months: 3

Version 60 of 60 (2024-11-01 to present)

Registration versions:

Version 60 of 60 (2024-11-01 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Industry, Research and Development, Taxation and Finance	Annual federal Budgets and Budget updates relating to the biopharmaceutical industry.	Policies or Program
Health	Bill C-64, An Act Respecting Pharmacare, and related federal health policies and programs.	Policies or Program, Legislative Proposal, Bill or Resolution
Aboriginal Affairs, Government Procurement, Health	Federally-funded Public Drug Plans, including the Non Insured Health Benefits program, with respect to reimbursement for drug products for beneficiaries.	Policies or Program
Health, Research and Development	Implementation of the National Strategy for Drugs for Rare Diseases.	Policies or Program
Intellectual Property, International Trade	Patent Act, Patented Medicines (Notice of Compliance) Regulations, Data Protection Regulation, Certificates of Supplementary Protection and related policies regarding the regulation of intellectual property for biopharmaceutical products, and maintaining international competitiveness.	Regulation
Health, Industry, Research and Development	Patented Medicine Prices Review Board (PMPRB) regarding development and implementation of guidelines to operationalize regulatory amendments.	Policies or Program
Government Procurement, Health, Research and Development	Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as COVID-19 and RSV.	Policies or Program
Health, International Development, Research and Development	Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.	Policies or Program
Industry, International Development, Taxation and Finance	Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits.	Policies or Program
Health, Industry, Research and Development, Science and Technology	Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.	Policies or Program

Communication Techniques

Written communication
Oral communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Atlantic Canada Opportunities Agency (ACOA)
Canada Economic Development for Quebec Regions
Canada Foundation for Innovation
Canada Revenue Agency (CRA)
Canadian Institutes of Health Research (CIHR)
Canadian International Trade Tribunal (CITT)
Canadian Northern Economic Development Agency (CanNor)
Competition Bureau Canada (COBU)
Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
International Development Research Centre (IDRC)
National Defence (DND)
National Research Council (NRC)
Natural Sciences and Engineering Research Council (NSERC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)
Royal Canadian Mounted Police (RCMP)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)
Veterans Affairs Canada (VAC)

In-house Corporation Details

Description of activities

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca’s Canadian headquarters are located in Mississauga, Ontario. For more information, please visit the company’s website at www.astrazeneca.ca.

Responsible officer name and position during the period of this registration

Gaby Bourbara, President

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
1004 Middlegate Road, Suite 5000
Mississauga, ON L4Y 1M4
Canada

Telephone number: 800-565-5877

Parent Company Information

AstraZeneca PLC
- 1 Francis Crick Avenue
  Cambridge Biomedical Campus
  Cambridge CB20AA
  United Kingdom

Subsidiary Beneficiary Information

AstraZeneca Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Denise Lacombe, Head of Legal | No public offices held
Pascal Soriot, Chief Executive | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Jon Feairs, Director, Government Affairs & Public Policy | No public offices held
Isabelle Gagnon, Senior Manager, Government Affairs Federal | No public offices held
Ilias Iliopoulos, Head- Payer Engagement & Strategic Partnerships | No public offices held
Carlo Mastrangelo, Head - Corporate Affairs, Communications & Sustainability | No public offices held
Heather McDonald, Vice President, Market Access and Pricing | No public offices held
Dale Payne, Senior Manager, National Policy and Partnerships | No public offices held
Gena Restivo, VP, Corporate Affairs & Sustainability | No public offices held
Alex Romanovschi, Vice President, Scientific Affairs | No public offices held
Jean-Sebastien Roy, Director, Strategic Pricing | No public offices held
Noel Saraza, Senior Manager, Payer Relations | No public offices held

AstraZeneca Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
AstraZeneca Canada Inc.	2008-07-31	current

The following names have been used before July 2, 2008

AstraZeneca Canada Inc.

AstraZeneca Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Gaby Bourbara	2024-03-01	Current
Kiersten Combs	2021-09-01	2024-03-01
Jane Chung	2019-11-01	2021-09-01
Daniel Smedley	2019-08-01	2019-11-01
Jamie Freedman	2017-11-28	2019-08-01
Ed Dybka	2015-01-02	2017-11-28
Elaine Campbell	2012-01-09	2015-01-02
Marion McCourt	2010-04-12	2012-01-09
Mark Jones	2007-03-08	2010-04-12

Date Modified:: 2025-03-12

Search and menus

Language selection

Registration - In-house Corporation

AstraZeneca Canada Inc. / Gaby Bourbara, President

Registration Information

Associated Communications

Version 60 of 60 (2024-11-01 to present)

Version 60 of 60 (2024-11-01 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties